Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Endo Pharmaceuticals Holdings (NQ: ENDP)
33.73 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Endo Pharmaceuticals Holdings
 
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Buckingham Research Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Buy
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8346024 for the full story. Read More
from StreetInsider.com News Articles
(ENDP) Endo Health Solutions Sees FDA Setback on Opana ER
May 15, 2013
Endo Health Solutions Inc. (ENDP) recently suffered a setback with the US Food and Drug... Visit StockBlogHub to view complete post. Read More
category Lannett Company Inc , CELG , Cubist Pharmaceuticals Inc/ , and 9 more.
from Stock Blog Hub
Endo Health Solutions Inc. (NASDAQ:ENDP), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and JetBlue Airways Corporation (NASDAQ:JBLU) Added to Equity Profile Report's NASDAQ Active Stock Watch List.
May 15, 2013
Wilmington, DE -- (SBWIRE) -- 05/15/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Endo Health Solutions Inc. (NASDAQ:ENDP), NPS Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
NASDAQ Active Stock Watch List: Endo Health Solutions Inc. (NASDAQ:ENDP), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and JetBlue Airways Corporation (NASDAQ:JBLU) Added to Growing Stock Report's NASDAQ
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Endo Health Solutions Inc. (NASDAQ:ENDP), NPS Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
AFFY, GALE, and AVEO added to BioStock Watch List at GSR
May 14, 2013
from ACCESSWIRE
Streetinsider.com's Hot Lunchtime Reads 05/14: (TMUS) (FIO) (SODA) (V)
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8335938 for the full story. Read More
from StreetInsider.com News Articles
Noteworthy ETF Outflows: XPH, ENDP, WCRX, SLXP
May 14, 2013
Symbols mentioned in this story: XPH, ENDP, WCRX, SLXP Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Gabelli Sees Buying Opp in Endo Health (ENDP)
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8335719 for the full story. Read More
from StreetInsider.com News Articles
Top Losers: Affymax, Inc.(NASDAQ:AFFY), AVEO Pharmaceuticals, Endo Health Solutions Inc, Fusion-IO, Inc.(NYSE:FIO)
May 14, 2013
Austin, TX -- (SBWIRE) -- 05/14/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga
May 14, 2013
from PR Newswire
Biocare Decliners Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE), Affymax, Inc. (NASDAQ:AFFY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), and Endo Health Solutions Inc. (NASDAQ:ENDP) Added to G
May 14, 2013
New York, NY -- (SBWIRE) -- 05/14/2013 -- Growing Stock Report expands its Biocare Decliners Weekly Watch List adding Galena Biopharma, Inc. (NASDAQ:GALE), Affymax, Inc. (NASDAQ:AFFY), AVEO... Read More
from SBWire - Latest Press Releases
Free Research Reports on ENDP, MOBI, MOS and POST Issued by the Paragon Report
May 14, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: GLW, ENDP and ANR
May 14, 2013
from Marketwired News Releases
Downtrend Stocks Momentum (ENDP, MCP, S, AGNC)
May 13, 2013
New York, NY -- (SBWIRE) -- 05/13/2013 -- Endo Health Solutions Inc (NASDAQ:ENDP) fell -2.77% to $34.00 and ranged between $32.66 and $34.19. The sharp decline appeared after it disclosed that the U.S.... Read More
from SBWire - Latest Press Releases
Analyst Moves: ENDP, PRU, AZO
May 13, 2013
This morning, UBS reduced its price target on shares of Endo Health Solutions (ENDP) to $39 per share following an unfavorable FDA ruling last week. In the report, UBS slashed its EPS estimates as... Read More
category Stocks
from Market News Video
Endo Health Solutions (ENDP) falls on downgrade
May 13, 2013
Endo Health Solutions Inc. (NASDAQ: ENDP) dipped 2.6% to $34.05 after the company was downgraded by analysts at Lazard from “neutral” to “sell”. Share volume was better than four million, compared to... Read More
from BAYSTREET RSS FEED
UPDATE: Jefferies Lowers PT on Endo Pharmaceuticals Following FDA Decision
May 13, 2013
In a report published Monday, Jefferies analyst Corey Davis reiterated a Buy rating on Endo Pharmaceuticals Holdings (NASDAQ: ENDP ), but lowered the price target from $47.00 to $37.00. In the report,... Read More
category Benzinga , ENDP , Price Target , and 3 more.
from Latest Articles from Benzinga.com
Shares of Endo Pharmaceuticals Down on Above Average Volume, Moving Against Trend (ENDP)
May 13, 2013
from Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes 05/13: (NOK) (GLW) (OC) Upgraded; (ENDP) (AZO) (M) Downgraded
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8330724 for the full story. Read More
from StreetInsider.com News Articles
Benzinga's Top Pre-Market Losers
May 13, 2013
Endo Health Solutions Inc. (NASDAQ: ENDP ) dipped 4.78% to $1.67 in the pre-market session after the company was downgraded by analysts at Lazard from “neutral” to “sell”. Central European Media... Read More
category RTN , Benzinga , Benzinga's Top Pre/Market Losers , and 8 more.
from Latest Articles from Benzinga.com
FDA Not Buying Endo Health’s Painkiller Ploy
May 13, 2013
category ENDP
from YCharts
CRT Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Fairly Valued
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8330130 for the full story. Read More
from StreetInsider.com News Articles
William Blair Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Market Perform
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8330127 for the full story. Read More
from StreetInsider.com News Articles
Jefferies Cuts Numbers on Endo Pharmaceuticals (ENDP) After 'Irrational' FDA Decision
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329696 for the full story. Read More
from StreetInsider.com News Articles
Lazard Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Sell
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329647 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise... Read More
category companyNews
from Reuters: Company News
FDA Rejects Endo Petition To Protect Its Opana Painkiller
May 10, 2013
In a rebuff to Endo Health Solutions, the FDA has denied a citizen petition that the drugmaker had filed last year in an attempt to thwart generic competition to its Opana ER painkiller. The decision... Read More
category NASDAQ:ENDP
from Forbes Real Time
FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise... Read More
category companyNews
from Reuters: Company News
BRIEF-Endo Health down 2.8 percent in extended trade
May 10, 2013
NEW YORK, May 10 (Reuters) - Endo Health Solutions Inc : * Down 2.8 percent to $34 in extended trade after FDA decision on generic versions of Endo's Opana ER Read More
category companyNews
from Reuters: Company News
Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
May 10, 2013
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here